What Researchers Did
Researchers retrospectively examined the medical records of patients treated with hyperbaric oxygen therapy for bleeding bladder inflammation caused by radiation.
What They Found
Out of 52 patients treated with a median of 30 sessions, 69.2% experienced a complete response and 21.2% a partial response to hyperbaric oxygen therapy. Hospitalizations due to bleeding bladder inflammation significantly decreased from 2.8 to 1.1 per year, and 73.5% of patients reported feeling "very much better" or "much better" after treatment. The therapy was well-tolerated, though 15.4% of patients experienced recurrence and 9.6% eventually needed bladder removal surgery.
What This Means for Canadian Patients
For Canadian patients suffering from hemorrhagic radiation cystitis, these findings suggest that hyperbaric oxygen therapy could be an effective treatment to reduce bleeding and associated hospitalizations. It offers a promising non-surgical option to improve quality of life by alleviating symptoms and potentially preventing more invasive procedures.
Canadian Relevance
This study covers hemorrhagic radiation cystitis, a condition for which hyperbaric oxygen therapy is a Health Canada-recognized indication.
Study Limitations
As a retrospective study conducted at a single centre, these findings may be subject to selection bias and might not be generalizable to all patient populations.